Can a common drug stop infections before they start?
NCT ID NCT07054320
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether the drug rapamycin (sirolimus) can help prevent infections or make them less severe. Fifteen adults will take the drug for 6 months while researchers monitor their health through blood tests, heart checks, and surveys. The goal is to see if rapamycin is safe and effective for reducing infection-related illness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIOUS DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hoskinson Health and Wellness Clinic
Gillette, Wyoming, 82718, United States